Norak Biosciences

Business Services · 11-50 Employees

View Company Info for Free

Overview

Phone Number

(919) 248-8000

Revenue

$6.5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Norak Biosciences

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company utilizing its proprietary Transfluor® technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors (GPCRs). For long-term growth and value, the Company is utilizing its technology as a competitive advantage to discover and develop a pipeline of GPCR-based drug candidates. For near-term growth and revenue, Norak is offering limited access to Transfluor® via direct licensing to major pharmaceutical companies and to smaller companies via screening service. To date, Merck and AstraZeneca have licensed Transflour, and evaluations/discussions are on going with additional companies. Transfluor is a patented, fluorescence-based, universal GPCR drug discovery technology designed to be the most direct and accurate method for screening potential drug candidates against GPCR targets, whether known or unknown (orphan). Transfluor arisesRead more
Norak Biosciences's Social MediaPopular SearchesNorak Biosciences IncSIC Code 87,873NAICS Code 54,541Show more

Is Norak Biosciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Norak Biosciences

Compare insights from companies similar to Norak Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Norak Biosciences

$6.5M
11-50
Private
-
-
N/A
$22.6M
51-200
Private
-
1994
LS
Ludmila SadovenkoDirector, Marketing
$11.1M
11-50
Private
<$5M
2005
Patty Ferrante, Chief Operating Officer at Melior Discovery
Patty FerranteChief Operating Officer
$10M
11-50
Private
$11.2M
-
$7.2M
11-50
Private
<$5M
2009
<$5M
11-50
Private
-
2006
N/A
<$5M
11-50
Private
-
2004
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Norak Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Norak Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Norak Biosciences.

Norak Biosciences Tech Stack

A closer look at the technologies used by Norak Biosciences

Top Business Services Companies

Frequently Asked Questions Regarding Norak Biosciences

What is Norak Biosciences's official website?
Norak Biosciences's official website is www.norakbio.com
What is Norak Biosciences's Revenue?
Norak Biosciences's revenue is $6.5 Million
What is Norak Biosciences's SIC code?
Norak Biosciences's SIC: 87,873
What is Norak Biosciences's NAICS code?
Norak Biosciences's NAICS: 54,541
How many employees does Norak Biosciences have?
Norak Biosciences has 11-50 employees
What industry does Norak Biosciences belong to?
Norak Biosciences is in the industry of: Business Services, Research & Development
What is Norak Biosciences competition?
Norak Biosciences top competitors include: Multispan, Asinex, Araceli Biosciences, CMD Bioscience
What technology does Norak Biosciences use?
Some of the popular technologies that Norak Biosciences uses are: YouTube, ASP.NET, BigCommerce, GitHub Pages
How do I contact Norak Biosciences?
Norak Biosciences contact info: Phone number: (919) 248-8000 Website: www.norakbio.com
What does Norak Biosciences do?

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company utilizing its proprietary Transfluor® technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors (GPCRs). For long-term growth and value, the Company is utilizing its technology as a c... ompetitive advantage to discover and develop a pipeline of GPCR-based drug candidates. For near-term growth and revenue, Norak is offering limited access to Transfluor® via direct licensing to major pharmaceutical companies and to smaller companies via screening service. To date, Merck and AstraZeneca have licensed Transflour, and evaluations/discussions are on going with additional companies. Transfluor is a patented, fluorescence-based, universal GPCR drug discovery technology designed to be the most direct and accurate method for screening potential drug candidates against GPCR targets, whether known or unknown (orphan). Transfluor arises from technology that was developed at Duke University Medical Center and licensed by Norak in 1999. The Transfluor technology reflects the combined research into GPCR signaling pathways over several decades by Norak's scientific founders, Drs. Marc Caron, Robert Lefkowitz, and Larry Barak.Read More

What are Norak Biosciences social media links?
Norak Biosciences Linkedin page
Is Norak Biosciences a public company?
Norak Biosciences is private company therefore does not currently have an official ticker symbol
See more information about Norak Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.